Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
Julphar
Boehringer Ingelheim
Express Scripts
US Department of Justice
Fish and Richardson
QuintilesIMS
Daiichi Sankyo

Generated: May 21, 2018

DrugPatentWatch Database Preview

NALLPEN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Nallpen, and what generic alternatives are available?

Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in NALLPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Summary for NALLPEN
Drug patent expirations by year for NALLPEN
Medical Subject Heading (MeSH) Categories for NALLPEN
Synonyms for NALLPEN
(2-ethoxy-1-naphthalenyl)penicillin
(2-Ethoxy-1-naphthyl)penicillin
(2S,5R,6R)-6-({[2-(ethyloxy)naphthalen-1-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-(2-ethoxynaphthalene-1-amido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
147-52-4
177N506
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2-ethoxy-1-naphthalenyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[(2-ethoxy-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-
4CNZ27M7RV
6-(2-ethoxy-1-naphthamido)penicillanic acid
6-[(2-Ethoxy-naphthalene-1-carbonyl)-amino]-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion
6beta-(2-ethoxynaphthalene-1-carboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid
7177-50-6
985-16-0
985-16-0 (mono-hydrochloride salt, anhydrous)
AC1L1S2D
API0003482
BDBM50103525
BPBio1_000909
BRD-K18574842-323-03-3
BRN 0862393
BSPBio_000825
C07250
C21H22N2O5S
CHEBI:7447
CHEMBL1443
D08242
D0A0JH
DB00607
DTXSID8023343
EINECS 205-690-9
Epitope ID:141583
FT-0700018
GPXLMGHLHQJAGZ-JTDSTZFVSA-N
HSDB 3133
LS-149872
nafcilin
Nafcilin-1
Nafcilina
Nafcilina [INN-Spanish]
nafcillin
Nafcillin (INN)
Nafcillin [INN:BAN]
Nafcillin & VRC3375
NAFCILLIN SODIUM
Nafcillin sodium for injection
Nafcillin sodium salt
Nafcillin, Antibiotic for Culture Media Use Only
Nafcillin, Monosodium Salt, Anhydrous
Nafcilline
Nafcilline [INN-French]
Nafcillinum
Nafcillinum [INN-Latin]
Nallpen In Plastic Container
Naphcillin
Naphthamidopenicillin
Penicillin, (2-ethoxy-1-naphthalenyl)-
Penicillin, (2-ethoxy-1-naphthyl)-
Prestwick0_000843
Prestwick1_000843
Prestwick2_000843
Prestwick3_000843
SCHEMBL47797
Sodium nafcillin
SPBio_002746
UNII-4CNZ27M7RV
Unipen
W-108115
ZINC3875980

US Patents and Regulatory Information for NALLPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline NALLPEN nafcillin sodium INJECTABLE;INJECTION 061999-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare NALLPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050655-002 Oct 31, 1989 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline NALLPEN nafcillin sodium INJECTABLE;INJECTION 062755-002 Dec 19, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare NALLPEN IN PLASTIC CONTAINER nafcillin sodium INJECTABLE;INJECTION 050655-001 Oct 31, 1989 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Fish and Richardson
Cipla
Farmers Insurance
McKesson
Fuji
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.